Elite Diagnostic Limited (JMSE:ELITE)

Elite Diagnostic Revenue

In the fiscal year ending June 30, 2026, Elite Diagnostic had annual revenue of 867.30M JMD with 1.58% growth. Elite Diagnostic had revenue of 216.52M in the quarter ending June 30, 2026, a decrease of -3.77%.

• Revenue: 867.30M
• Revenue Growth: +1.58%
• P/S Ratio: 0.53
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 459.42M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	867.30M	13.48M	1.58%
Jun 30, 2025	853.82M	32.54M	3.96%
Jun 30, 2024	821.28M	65.95M	8.73%
Jun 30, 2023	755.33M	131.11M	21.00%
Jun 30, 2022	624.22M	117.31M	23.14%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 17, 2026

Data Sources Report a data error